Highlights and Quick Summary
- Research and Development (R&D) Expenses Growth for the quarter ending September 30, 2023 was -28.96% (a 13.93% increase compared to previous quarter)
- Year-over-year quarterly Research and Development (R&D) Expenses Growth increased by 2.59%
- Annual Research and Development (R&D) Expenses Growth for 2022 was 32.12% (a -88.9% decrease from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2021 was 289.47% (a 74.85% increase from previous year)
- Annual Research and Development (R&D) Expenses Growth for 2020 was 165.55% (a -365.56% decrease from previous year)
- Twelve month Research and Development (R&D) Expenses Growth ending September 30, 2023 was -25.64% (a 115.82% increase compared to previous quarter)
- Twelve month trailing Research and Development (R&D) Expenses Growth decreased by -179.83% year-over-year
Trailing Research and Development (R&D) Expenses Growth for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| -25.64% | -11.88% | 4.45% | 32.12% |
Visit stockrow.com/ABSI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development (R&D) Expenses Growth of Absci Corporation
Most recent Research and Development (R&D) Expenses Growthof ABSI including historical data for past 10 years.Interactive Chart of Research and Development (R&D) Expenses Growth of Absci Corporation
Absci Corporation Research and Development (R&D) Expenses Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | -28.96% | -25.42% | -20.03% | – | – |
| 2022 | -28.23% | 44.69% | 47.11% | 124.5% | 32.12% |
| 2021 | 242.96% | 298.59% | 390.23% | 269.69% | 289.47% |
| 2020 | -70.84% | -74.91% | -79.6% | -72.95% | 165.55% |
| 2019 | – | – | – | – | -62.34% |
Business Profile of Absci Corporation
Sector: Healthcare
Industry: Biotechnology